Show simple item record

dc.contributor.authorCouch, Georgeen
dc.contributor.authorRedman, James Een
dc.contributor.authorWernisch, Lorenzen
dc.contributor.authorNewton, Richarden
dc.contributor.authorMalhotra, Shalinien
dc.contributor.authorDawsey, Sanford Men
dc.contributor.authorLao-Sirieix, Pierreen
dc.contributor.authorFitzgerald, Rebeccaen
dc.date.accessioned2016-04-26T11:02:58Z
dc.date.available2016-04-26T11:02:58Z
dc.date.issued2016-07en
dc.identifier.citationCancer Prevention Research 2016. DOI: 10.1158/1940-6207.CAPR-15-0379en
dc.identifier.issn1940-6207
dc.identifier.urihttps://www.repository.cam.ac.uk/handle/1810/255707
dc.description.abstractThe 5-year survival rate of esophageal cancer is less than 10% in developing countries, where more than 90% of these cancers are esophageal squamous cell carcinomas (ESCC). Endoscopic screening is undertaken in high incidence areas. Biomarker analysis could reduce the subjectivity associated with histologic assessment of dysplasia and thus improve diagnostic accuracy. The aims of this study were therefore to identify biomarkers for esophageal squamous dysplasia and carcinoma. A publicly available dataset was used to identify genes with differential expression in ESCC compared with normal esophagus. Each gene was ranked by a support vector machine separation score. Expression profiles were examined, before validation by qPCR and IHC. We found that 800 genes were overexpressed in ESCC compared with normal esophagus (P < 10(-5)). Of the top 50 genes, 33 were expressed in ESCC epithelium and not in normal esophagus epithelium or stroma using the Protein Atlas website. These were taken to qPCR validation, and 20 genes were significantly overexpressed in ESCC compared with normal esophagus (P < 0.05). TNFAIP3 and CHN1 showed differential expression with IHC. TNFAIP3 expression increased gradually through normal esophagus, mild, moderate and severe dysplasia, and SCC (P < 0.0001). CHN1 staining was rarely present in the top third of normal esophagus epithelium and extended progressively towards the surface in mild, moderate, and severe dysplasia, and SCC (P < 0.0001). Two novel promising biomarkers for ESCC were identified, TNFAIP3 and CHN1. CHN1 and TNFAIP3 may improve diagnostic accuracy of screening methods for ESCC. Cancer Prev Res; 9(7); 558-66. ©2016 AACR.
dc.description.sponsorshipThe Addenbrooke's Hospital Human Research Tissue Bank, supported by the NIHR Cambridge Biomedical Research Centre (5-4690), supported this study. R.C. Fitzgerald received funding from the NIHR (NIHR-RP-R2-12-011) and the Evelyn Trust (11/23). This study was also supported in part by the intramural research program of the NCI (HHSNZ 61201100483P). R.C. Fitzgerald has programmatic funding from the Medical Research Council (4050375780) and a National Institute of Health Research (NIHR) Professorship. The Fitzgerald Group also has infrastructure support from the Biomedical Research Centre (812039) and the Experimental Medicine Centre (C507/A15580).
dc.languageengen
dc.language.isoenen
dc.publisherAmerican Association for Cancer Research
dc.subjectBiomarkers, Tumoren
dc.subjectCarcinoma, Squamous Cellen
dc.subjectChimerin 1en
dc.subjectEsophageal Neoplasmsen
dc.subjectEsophageal Squamous Cell Carcinomaen
dc.subjectGene Expression Profilingen
dc.subjectHumansen
dc.subjectPrecancerous Conditionsen
dc.subjectTranscriptomeen
dc.subjectTumor Necrosis Factor alpha-Induced Protein 3en
dc.titleThe Discovery and Validation of Biomarkers for the Diagnosis of Esophageal Squamous Dysplasia and Squamous Cell Carcinoma.en
dc.typeArticle
prism.endingPage566
prism.issueIdentifier7en
prism.publicationDate2016en
prism.publicationNameCancer Prevention Researchen
prism.startingPage558
prism.volume9en
dc.rioxxterms.fundernihr
dc.rioxxterms.funderMRC
dcterms.dateAccepted2016-03-11en
rioxxterms.versionofrecord10.1158/1940-6207.CAPR-15-0379en
rioxxterms.licenseref.urihttp://www.rioxx.net/licenses/all-rights-reserveden
rioxxterms.licenseref.startdate2016-07en
dc.contributor.orcidFitzgerald, Rebecca [0000-0002-3434-3568]
dc.identifier.eissn1940-6215
rioxxterms.typeJournal Article/Reviewen
pubs.funder-project-idMedical Research Council (MC_UU_12022/2)
pubs.funder-project-idMRC (unknown)
pubs.funder-project-idTCC (NIHR-RP-02-12-011)
cam.issuedOnline2016-04-12en
cam.orpheus.successThu Jan 30 12:54:39 GMT 2020 - Embargo updated*


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record